Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs InstaRX

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, InstaRX a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

InstaRX

#278 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full InstaRX review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 68 an est. $99/mo first month, with no teaser step-up baked in. InstaRX isn't out of it: Shoppers who want compounded GLP-1 plus peptides and sexual health on one account.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDInstaRX
Value Score89 (A)68 (C)
Est. first month$99/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~93%~85%
Semaglutide$99/moFrom $199/mo (starting dose, compounded)
Tirzepatide$139/moFrom $199/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
72
bmiMD: 95. InstaRX: 72.
84
No Teaser-Rate Bait
38
bmiMD: 84. InstaRX: 38.
98
Nationwide Availability
96
bmiMD: 98. InstaRX: 96.
94
Both Molecules
92
bmiMD: 94. InstaRX: 92.
82
Easy Cancellation
58
bmiMD: 82. InstaRX: 58.
70
Reputation
58
bmiMD: 70. InstaRX: 58.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

InstaRX

InstaRX is a multi-product compounded-medication telehealth platform offering GLP-1 injections (semaglutide and tirzepatide) alongside anti-aging peptides (NAD+, Sermorelin, B12/MIC) and sexual-health…

Why it's a deal

  • Available in all 50 states plus DC
  • Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
  • Offers both compounded semaglutide and compounded tirzepatide
  • Independent provider group (Dr Telx) named in the Terms of Service

The fine print

  • No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
  • No LegitScript, HIPAA, or NABP accreditation shown on public pages
  • Compounding pharmacy not named — only "U.S. pharmacies"
  • Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
  • Delaware governing law for disputes despite a California corporate address
Get the bmiMD deal Get the InstaRX deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to InstaRX.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.